Cytotoxic drugs, programmed cell death, and the immune system: Defining new roles in an old play

被引：63
作者：
Debatin, KM [1 ]
机构：
[1] GERMAN CANC RES CTR,DIV MOL ONCOL,D-6900 HEIDELBERG,GERMANY
来源：
JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1997年 / 89卷 / 11期
关键词：
D O I：
10.1093/jnci/89.11.750
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：750 / 751
页数：2
相关论文
共 17 条
[1]  
Debatin KM, 1996, CELL DEATH DIFFER, V3, P185
[2]   TEMPORARY REMISSIONS IN ACUTE LEUKEMIA IN CHILDREN PRODUCED BY FOLIC ACID ANTAGONIST, 4-AMINOPTEROYL-GLUTAMIC ACID (AMINOPTERIN) [J].
FARBER, S ;
DIAMOND, LK ;
MERCER, RD ;
SYLVESTER, RF ;
WOLFF, JA .
NEW ENGLAND JOURNAL OF MEDICINE, 1948, 238 (23) :787-793
[3]   APOPTOSIS IN CANCER-THERAPY - CROSSING THE THRESHOLD [J].
FISHER, DE .
CELL, 1994, 78 (04) :539-542
[4]   Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells [J].
Friesen, C ;
Herr, I ;
Krammer, PH ;
Debatin, KM .
NATURE MEDICINE, 1996, 2 (05) :574-577
[5]   MAINTENANCE CHEMOTHERAPY AND CURE OF CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA [J].
GALE, RP ;
BUTTURINI, A .
LANCET, 1991, 338 (8778) :1315-1318
[6]   Potential involvement of fas and its ligand in the pathogenesis of Hashimoto's thyroiditis [J].
Giordano, C ;
Stassi, G ;
DeMaria, R ;
Todaro, M ;
Richiusa, P ;
Papoff, G ;
Ruberti, G ;
Bagnasco, M ;
Testi, R ;
Galluzzo, A .
SCIENCE, 1997, 275 (5302) :960-963
[7]   Melanoma cell expression of Fas(Apo-1/CD95) ligand: Implications for tumor immune escape [J].
Hahne, M ;
Rimoldi, D ;
Schroter, M ;
Romero, P ;
Schreier, M ;
French, LE ;
Schneider, P ;
Bornand, T ;
Fontana, A ;
Lienard, D ;
Cerottini, JC ;
Tschopp, J .
SCIENCE, 1996, 274 (5291) :1363-1366
[8]   ICE family proteases: Mediators of all apoptotic cell death? [J].
Henkart, PA .
IMMUNITY, 1996, 4 (03) :195-201
[9]  
Krammer PH, 1996, CELL DEATH DIFFER, V3, P159
[10]   Programmed cell death and radioresistance [J].
Meyn, RE ;
Stephens, LC ;
Milas, L .
CANCER AND METASTASIS REVIEWS, 1996, 15 (01) :119-131
12